Media Outlet Highlights New Study Led by Researchers from the Fels Cancer Institute for Personalized Medicine and Fox Chase Cancer Center on Leukemia Gene Mutations and PARP Inhibitors

Tomasz Skorski, MD, PhD, DSc, Director of the Fels Cancer Institute for Personalized Medicine at the Lewis Katz School of Medicine at Temple University, is the senior author on a recent study published in the journal Cancer Research which identified specific leukemia gene mutations and the mechanisms by which they regulate DNA repair and respond to PARP inhibitors. The research was led by scientists from the Fels Cancer Institute for Personalized Medicine and Fox Chase Cancer Center. News-Medical.net highlighted the news.